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Salivary  gland  tumors  are  uncommon  and 
constitute 2–6.5% of all head and neck neoplasms.1 
Particularly,  tumors  of  minor  salivary  gland 
origin account for less than 25% of all salivary 
neoplasms.2 
Basal  cell  adenoma  is  a  benign  epithelial 
neoplasm with a uniform histologic appearance 
dominated  by  basaloid  cells.  According  to  its 
morphology  at  microscopical  levels,  basal 
cell  adenoma  has  been  classified  as  solid 
(monomorphic),  trabecular,  tubular  and 
membranous.3 However, basal cells are found in 
several primary salivary gland tumors either as 
a major component present in a mixture of cells 
types or as pure basal cell neoplasms.4 In this 
regard, the distinction between the true neoplasm 
and other primary tumors with basal cell features 
pose diagnostic sometimes difficult.5
In this current paper, we were able to report 
a case of basal cell adenoma from labial salivary 
gland  origin  in  a  Caucasian  woman  diagnosed 
by  means  of  histopathological  evaluation  and 
confirmed by immunohistochemistry. 
CASE REPoRt
A  51-years-old  Brazilian  Caucasian  woman 
was admitted in the Stomatology Service of the 
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AbStRACt
Basal cell adenoma is an uncommon benign salivary gland neoplasm, presenting isomorphic 
basaloid cells with a prominent basal cell layer. Taking into account that basal cell adenomas 
represent 1% of all salivary gland tumors, being the majority of cases in the parotid glands, the goal 
of this paper is to report a case of basal cell adenoma of the upper lip arising from minor salivary 
gland. (Eur J Dent 2008;2:213-216)
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at the Hospital of the Botucatu Medical School 
in  2006  with  a  painless  swelling  in  the  upper 
lip.  Intraoral  examination  revealed  a  hardened 
delimited nodule of 4 cm in diameter, presenting 
violet  color  covering  normal  mucosa  with  no 
ulceration (Figure 1). She related that the lesion 
begun 5 years ago, being its development slow, 
progressive and painless.  The clinical diagnostic 
was  established  as  pleomorphic  adenoma  or 
vascular  neoplasms.  After  that,  an  excisional 
biopsy was carried out by a dentist under local 
anesthesia and the specimen was put into 10% 
buffer formalin. During the surgery, the behavior 
of  lesion  was  similar  to  vascular  neoplasm,  in 
which there was blooding when the capsule of 
the lesion was ruptured.  
The  specimen  underwent  histotechnical 
procedures  and  was  stained  with  hematoxylin 
and  eosin  (H.E.).  Microscopically,  the  tumor  is 
composed  of  isomorphic  basaloid  cells  with  a 
prominent basal cell layer, a distinct basement 
membrane-like structure and no mucoid stromal 
component as in pleomorphic adenomas (Figure 
2).  In  order  to  confirm  the  diagnosis  on  H.E. 
slides,  immunohistochemistry  was  performed 
in this case. Thus, serial sections of 4 µm were 
deparaffinized  in  xylene  and  rehydrated  in 
graded ethanol, then pretreated in a microwave 
(Electrolux,  SP,  Brazil)  with  10mM  citric  acid 
buffer (pH=6) for 3 cycles of 5 min each at 850 
W for antigen retrieval. They were pre-incubated 
with 0.3% hydrogen peroxide in PBS for 5 min for 
inactivation of endogenous peroxidase, and then 
blocked with 5% normal goat serum in PBS for 
10 min. The specimens were then incubated with 
anti-cytokeratin 7 polyclonal antibody (Santa Cruz 
Biotechnology, USA) at a concentration of 1:100 
or anti-calponin (Santa Cruz Biotechnology, USA) 
at 1:200 concentrations. Incubation was carried 
out overnight at 4oC within the refrigerator. This 
was followed by two washes in PBS for 10 min. 
The  sections  were  then  incubated  with  biotin-
conjugated  secondary  antibody  anti-rabbit  IgG 
(Vector  Laboratories,  Burlingame,  CA,  USA)  at 
a  concentration  of  1:200  in  PBS  for  1  h.  After 
that,  the  sections  were  washed  twice  with 
PBS  followed  by  the  application  of  preformed 
avidin  biotin  complex  conjugated  to  peroxidase 
(Vector Laboratories, Burlingame, CA, USA) for 
45  min.  The  bound  complexes  were  visualized 
by  the  application  of  a  0.05%  solution  of  3-3’-
diaminobenzidine  solution,  and  counterstained 
with Harrys hematoxylin. For control studies of 
the antibodies, the serial sections were treated 
with rabbit IgG (Vector Laboratories, Burlingame, 
CA, USA) at a concentration of 1:200 in place of 
the primary antibody. 
The  immunohistochemical  findings  showed 
expressivity  either  to  cytokeratin  (Figure  3)  or 
to  calponin  (Figure  4).  Both  immunomarkers 
showed a strong pattern in tumor cells. Taken 
as  a  whole,  these  findings  supported  the  final 
diagnosis  of  basal  cell  adenoma  in  the  upper 
lip. No recurrences were detected up to now (six 
months after surgery). 
dISCuSSIoN
Salivary  gland  tumors  are  uncommon, 
comprising  less  than  3%  of  all  head  and  neck 
tumors.6 The majority of salivary gland tumors 
were  located  in  the  parotid  gland.7,8  These 
neoplasms point out predominance of benign over 
Figure 1. Clinical presentation of basal cell adenoma. Figure 2. Photomicrography of basal cell adenoma (H.E. stain, 
x100 magnification).
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malignant tumors.9 In most studies, pleomorphic 
adenoma  is  the  most  common  minor  salivary 
gland tumors9 with a incidence ranging from 33% 
to 70% of all and from 70.6% to 100% of benign 
tumors,10,11 with incidence for about 33% of total.6 
With  respect  to  basal  cell  adenoma,  it  is  an 
uncommon benign salivary gland neoplasm and 
the majority of cases arise in the parotid gland of 
elderly patients.12 Herein, the goal of this paper 
is to report a case of basal cell adenoma arising 
from minor salivary gland of the upper lip.
Microscopically,  minor  salivary  glands 
tumors  constitute  a  heterogeneous  group 
of  neoplasms  with  great  histomorphologic 
variation.13 Regarding basal cell adenomas, they 
may  present  form  solid  trabecular  structures 
and  cords  of  neoplastic  epithelial  cells  with 
peripheral layer of cell demonstrating palisading. 
The  stroma  may  be  quite  vascular,  but  it  does 
not have the myxoid quality seen in pleomorphic 
adenoma. In this report, basal cell adenoma was 
classified as solid variant consisting of uniform-
appearing  with  small  cells  (Figure  2).  These 
were arranged in large compact aggregates in 
which the outer layer is palisaded. In addition, 
intercellular  deposits  and  basiquamous  whorls 
in  the  globular  ends  of  epithelial  islands  were 
found. It is important to stress that challenges 
to  microscopic  diagnosis  include  biphasic 
differentiation of salivary gland tumors even to 
the point of hybrid tumors with features of two 
different, well-defined tumor entities.14 With few 
immunohistochemical  markers  available  for 
differentiation of tumors, accurate diagnosis of 
minor salivary gland tumor may be quite difficult. 
In order to help the histopathological diagnosis, 
we  decided  to  use  the  immunohistochemistry. 
Such  data  have  demonstrated  strong  positivity 
for  calponin  antibody  (Figure  3),  a  marker  of 
myoepitelial cells, and cytokeratin (Figure 4), an 
immunomarker  for  epithelial  cells.  Therefore, 
this  emphasizes  its  epithelial  and  glandular 
origin. 
Most studies have shown that minor salivary 
gland tumors are more common in females than 
males with a male-to-female ratio ranging from 
1:1.02 to 1:2.0.2 Moreover, major studies have also 
reported that the palate was the most common 
site  for  minor  salivary  gland  tumors  and  that 
approximately 40–80% of all tumors occurred in 
this site.1 In this case, the patient was female and 
the upper lip was the site of involvement of basal 
cell adenoma. 
Altogether,  this  report  supports  the  belief 
that  the  precise  identification  of  lesions  in  the 
upper lip is important, particularly because basal 
cell  adenoma  has  a  potential  to  malignancy, 
as  for  example  the  conversion  to  basal  cell 
adenocarcinoma. 
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